EC Number |
Inhibitors |
Structure |
---|
3.2.1.20 | (-)-epigallocatechin gallate |
- |
|
3.2.1.20 | (1R,5R)-3-methylidene-6,8-bis[(1S)-1-phenylethyl]-6,8-diazabicyclo[3.2.2]nonane-7,9-dione |
- |
|
3.2.1.20 | (1R,5R)-3-methylidene-6,8-diazabicyclo[3.2.2]nonane-7,9-dione |
- |
|
3.2.1.20 | (1S,5S)-3-methylidene-6,8-bis[(1S)-1-phenylethyl]-6,8-diazabicyclo[3.2.2]nonane-7,9-dione |
- |
|
3.2.1.20 | (1S,6S)-7,9-bis[(1S)-1-phenylethyl]-7,9-diazabicyclo[4.2.2]decane-8,10-dione |
- |
|
3.2.1.20 | (2E)-3-[(3-fluorophenyl)amino]-2-[4-(2-oxo-2H-chromen-3-yl)-1,3-thiazol-2-yl]prop-2-enenitrile |
75.2% inhibition at 50 microM |
|
3.2.1.20 | (2R,2'R,7R)-2,2'-dioctyl-5'-oxotetrahydro-4H-spiro[1,3-benzodioxole-5,4'-[1,3]dioxolan]-7-yl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
- |
|
3.2.1.20 | (2R,2'S,7R)-2,2'-dioctyl-5'-oxotetrahydro-4H-spiro[1,3-benzodioxole-5,4'-[1,3]dioxolan]-7-yl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
- |
|
3.2.1.20 | (2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol |
- |
|
3.2.1.20 | (2R,3S,4S)-1-[(2S,3S)-2,4-dihydroxy-3-(tridecyloxy)butyl]-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium |
- |
|